Savaria Co. (TSE:SIS – Get Free Report) Director Marcel Bourassa sold 7,500 shares of the stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of C$29.53, for a total transaction of C$221,475.00. Following the transaction, the director directly owned 225,431 shares in the company, valued at C$6,656,977.43. This trade represents a 3.22% decrease in their position.
Savaria Stock Down 1.3%
Shares of SIS traded down C$0.38 during trading hours on Friday, hitting C$28.89. The stock had a trading volume of 78,897 shares, compared to its average volume of 172,990. The company has a debt-to-equity ratio of 31.42, a current ratio of 1.71 and a quick ratio of 0.91. The firm has a 50 day simple moving average of C$28.96 and a 200-day simple moving average of C$26.03. The firm has a market capitalization of C$2.08 billion, a P/E ratio of 26.26, a price-to-earnings-growth ratio of 42.72 and a beta of 1.06. Savaria Co. has a 1-year low of C$18.71 and a 1-year high of C$30.62.
Savaria (TSE:SIS – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported C$0.31 EPS for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%.The business had revenue of C$235.54 million during the quarter. Sell-side analysts predict that Savaria Co. will post 1.2048518 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Savaria
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
